CA
VYNE icon

Centerpoint Advisors’s VYNE Therapeutics VYNE Stock Holding History

Centerpoint Advisors’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
350
– – ﹤0.01% 432
2025
Q4 		$0 Hold
350
– – ﹤0.01% 477
2025
Q3 		$0 Hold
350
– – ﹤0.01% 467
2025
Q2 		$1K Hold
350
– – ﹤0.01% 382
2025
Q1 		$1K Hold
350
– – ﹤0.01% 380
2024
Q4 		$1K Hold
350
– – ﹤0.01% 443
2024
Q3 		$1K Hold
350
– – ﹤0.01% 461
2024
Q2 		$1K Buy
+350
New +$873 ﹤0.01% 431

Other funds holding VYNE

AFM
Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $704M AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $73.3M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return